克罗塞丁在患有心力衰竭的老鼠中的预防和治疗作用
Renqiang Ma1,2, Sijia Li2, Qingmei Mo1,2
1Jiangsu Key Laboratory of TCM Evaluation and Translational Research, Research Center for Traceability and Standardization of TCMs, School of Traditional Chinese Pharmacy, China Pharmaceutical University, 639 Longmian Road, Nanjing 211198, China.
Pharmaceuticals (Basel, Switzerland)
|April 27, 2024
概括
克罗塞,来自花园,显示显著的治疗作用,慢性心力衰竭在老鼠. 预防性使用和长期使用克罗西治疗为改善心脏功能提供了最大的益处.
科学领域:
- 心血管研究研究心血管研究
- 药理学 药理学是指药理学的学科.
- 自然产品医学 自然产品医学
背景情况:
- 园丁花因其药用特性而闻名,特别是用于心血管保护.
- 克罗西是加德尼亚植物中重要的生物活性化合物,目前正在研究其治疗潜力.
- 慢性心力衰竭 (CHF) 仍然是一个重要的健康问题,有各种潜在原因.
研究的目的:
- 在慢性心力衰竭的老鼠模型中评估克罗塞丁的治疗疗效.
- 为了比较预防性和治疗性施用克罗塞丁的有效性.
- 确定不同剂量和治疗持续时间对冠状腺素在心血管疾病中的疗效的影响.
主要方法:
- 慢性心力衰竭模型通过腹腔大动脉收缩,性高血压和冠状动脉绑定在老鼠中被诱导.
- 评估了心脏功能,血液生物化学和组织病理学变化.
- 克罗塞丁的预防和治疗效果被评估在不同的施用策略.
主要成果:
- 克罗塞丁的使用,无论是预防性的还是治疗性的,在所有三种慢性心血管疾病的老鼠模型中都显著改善了结果.
- 预防性施用克罗塞丁与治疗性施用相比,显示出更高的疗效.
- 长期使用克罗塞丁 (超过6周) 比短期使用更有效.
结论:
- 克罗西作为慢性心力衰竭的治疗剂具有前景.
- 预防性和持续的克罗西的使用可能为控制心力衰竭提供最佳的益处.
- 对克罗西的机制和在心血管疾病中的临床应用进行进一步的研究是有必要的.
相关概念视频
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
422
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
422
01:26Heart Failure Drugs: Inotropic Agents
574
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
574
01:22Heart Failure Drugs: Diuretics
370
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
370
01:22Heart Failure Drugs: β-Blockers
337
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
337